• Journal of Information Management
• /
• v.41 no.3
• /
• pp.27-44
• /
• 2010

Most research about patent data analyzes the trend of technologies using a Patent Map(PM), and suggests the frequencies and trend of patents in a certain topic using tables or graphs in Excel. However, more advanced analysis tools are recently needed to compare the trends among national and international industries. This research discussed why statistical analysis is needed to improve the reliability in PM analysis, and the research compares the trends of patents in Korea between 1990 and 2004 by years, International Patent Classification(IPC) sections, and countries using the frequencies and Poisson regression model. The statistical analysis is also suggested and applied to R&D studies.

• KSBB Journal
• /
• v.28 no.6
• /
• pp.339-348
• /
• 2013

Translational research (TR) as high quality research can accelerate collaboration strongly between biotechnology-based researchers and clinical-research experts for overcoming diseases. TR facilitates basic science translated to clinical efficacy and effectiveness from bench (basic science) to bedside (clinical practice) for the enhancement of human health. Disease-oriented TR programs were defined as unilateral, bilateral and multilateral TR in this patent performance analysis. Patent performance was measured in a R&D project on Health and Medical Technology to enhance the productivity of R&D investment on disease-oriented TR in Health Technology (HT). Patent Map (PM) analysis and Bibliometrics were conducted to collect information for the assessment of research patents of TR programs. Futhermore, PIAS (Patent Information Analysis System) and Thinklear programs were applied for quantitative and qualitative analysis successfully. These indicate that multi-dimensional analysis of patent performance for disease-oriented TR could promote the connection of R&D-IP (Research and Development-Intellectural Property) and R&BD (Research and Business Development) supporting system significantly.

• Korean Chemical Engineering Research
• /
• v.50 no.5
• /
• pp.900-907
• /
• 2012

Research and development is entering on more complicated aspect gradually and tends to increase sharply in a quantitative manner. Technology competition is getting higher. This study intends to raise recognition of a necessity of productivity in a rapidly-changing research and development field and to suggest alternatives for improving its research productivity. For it, the research productivity was analyzed by utilizing two processes of patent and paper analysis. In this paper, we propose a patent analysis method for technology forecasting of the Forward Osmosis Membrane using objective patent data. The application status of patents showed a tendency to increase slightly. The current of FOM technology development in such countries as Korea, USA, Japan, China and EU was analyzed by classifying the patents for 1990 through 2011 according to registration country, assignee, calendar year and technology area.

• Journal of Radiation Protection and Research
• /
• v.42 no.1
• /
• pp.9-15
• /
• 2017

Background: The purpose of this study is to assign an appropriate density to virtual phantom for 2D diode array detector with different dose calculation algorithms to guarantee the accuracy of patient-specific QA. Materials and Methods: Ten VMAT plans with 6 MV photon beam and ten VMAT plans with 15 MV photon beam were selected retrospectively. The computed tomography (CT) images of MapCHECK2 with MapPHAN were acquired to design the virtual phantom images. For all plans, dose distributions were calculated for the virtual phantoms with four different materials by AAA and AXB algorithms. The four materials were polystyrene, 455 HU, Jursinic phantom, and PVC. Passing rates for several gamma criteria were calculated by comparing the measured dose distribution with calculated dose distributions of four materials. Results and Discussion: For validation of AXB modeling in clinic, the mean percentages of agreement in the cases of dose difference criteria of 1.0% and 2.0% for 6 MV were $97.2%{\pm}2.3%$, and $99.4%{\pm}1.1%$, respectively while those for 15 MV were $98.5%{\pm}0.85%$ and $99.8%{\pm}0.2%$, respectively. In the case of 2%/2 mm, all mean passing rates were more than 96.0% and 97.2% for 6 MV and 15 MV, respectively, regardless of the virtual phantoms of different materials and dose calculation algorithms. The passing rates in all criteria slightly increased for AXB as well as AAA when using 455 HU rather than polystyrene. Conclusion: The virtual phantom which had a 455 HU values showed high passing rates for all gamma criteria. To guarantee the accuracy of patent-specific VMAT QA, each institution should fine-tune the mass density or HU values of this device.